Peptide Therapeutics Global Market Report 2022: Featuring Amgen, Bachem, Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi, Takeda & Teva – ResearchAndMarkets.com

Peptide Therapeutics Global Market Report 2022: Featuring Amgen, Bachem, Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi, Takeda & Teva – ResearchAndMarkets.com




Peptide Therapeutics Global Market Report 2022: Featuring Amgen, Bachem, Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi, Takeda & Teva – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Peptide Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering.

This report on the global peptide therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global peptide therapeutics market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peptide therapeutics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the peptide therapeutics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peptide therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global peptide therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peptide therapeutics market.

The report delves into the competitive landscape of the global peptide therapeutics market. Key players operating in the global peptide therapeutics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global peptide therapeutics market profiled in this report.

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Peptide Therapeutics Market

4. Market Overview

5. Key Insights

6. Global Peptide Therapeutics Market Analysis and Forecast, by Application

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Application, 2017-2031

6.3.1. Cancer

6.3.2. Metabolic

6.3.3. CVD

6.3.4. Respiratory

6.3.5. GIT

6.3.6. Anti-infective

6.3.7. Dermatology

6.3.8. CNS

6.3.9. Renal

7. Global Peptide Therapeutics Market Analysis and Forecast, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Route of Administration, 2017-2031

7.3.1. Parenteral

7.3.2. Oral

7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Peptide Therapeutics Market Analysis and Forecast, by Type

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Type, 2017-2031

8.3.1. Innovative

8.3.2. Generic

8.4. Market Attractiveness Analysis, by Type

9. Global Peptide Therapeutics Market Analysis and Forecast, by Technology

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by Technology, 2017-2031

9.3.1. Liquid Phase

9.3.2. Solid Phase

9.3.3. Hybrid Phase

9.4. Market Attractiveness Analysis, by Technology

10. Global Peptide Therapeutics Market Analysis and Forecast, by Type of Molecule

10.1. Introduction & Definition

10.2. Key Findings / Developments

10.3. Market Value Forecast, by Type of Molecule, 2017-2031

10.3.1. Vasopressin

10.3.2. Somatostatin

10.3.3. Calcitonin

10.3.4. Natriuretic

10.4. Market Attractiveness Analysis, by Type of Molecule

11. Global Peptide Therapeutics Market Analysis and Forecast, by API Peptide Type

11.1. Introduction & Definition

11.2. Key Findings / Developments

11.3. Market Value Forecast, by API Peptide Type ,2017-2031

11.3.1. In-house

11.3.2. CMO

11.4. Market Attractiveness Analysis, by API Peptide Type

12. Global Peptide Therapeutics Market Analysis and Forecast, by Region

13. North America Peptide Therapeutics Market Analysis and Forecast

14. Europe Peptide Therapeutics Market Analysis and Forecast

15. Asia Pacific Peptide Therapeutics Market Analysis and Forecast

16. Latin America Peptide Therapeutics Market Analysis and Forecast

17. Middle East & Africa Peptide Therapeutics Market Analysis and Forecast

18. Competition Landscape

Companies Mentioned

  • Amgen, Inc.
  • Bachem Holding AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/2svz9a

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900